Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
5,848
Views
24
CrossRef citations to date
0
Altmetric
Coronaviruses

Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial

Xuan-Yi Wanga Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Fudan University, Shanghai, People’s Republic of China;c Children’s Hospital, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6398-9184
ORCID Icon,
Syed Faisal Mahmoodd Hospital of Aga Khan University, Karachi, Pakistan
,
Fang Jine State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, People’s Republic of China;f Guangzhou Joincare Respiratory Medicine Co., Ltd, Guangzhou, People’s Republic of China
,
Wee Kooi Cheahg Department of Medicine and Clinical Research Centre, Taiping Hospital, Perak, Malaysia
,
Muhammad Ahmadh Pulmonology & Critical care, Central Park Teaching Hospital, Lahore, Pakistan
,
Mian Amjad Sohaili Shifa International Hospitals Ltd, Islamabad, Pakistan
,
Waheed Ahmadj Avicenna Medical College, Lahore, Pakistan
,
Vijaya K. Suppank Clinical Research Center, Sultan Abdul Halim Hospital, Kedah, Malaysia
,
Muneeba Ahsan Sayeedl Department of Infectious Diseases, Sindh Infectious Diseases Hospital and Research Centre, Dow University of Health Sciences, Karachi, Pakistan
,
Shobha Luxmim Dow University of Health Sciences, Karachi, Pakistan
,
Aik-Howe Teon Penang General Hospital and Info Kinetics Clinical Research Centre, Pulau Pinang, Malaysia
,
Li Yuan Leeo CRC Seri Manjung Hospital, Perak, Malaysia
,
Yang-Yang Qia Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-9139-9675
ORCID Icon,
Rong-Juan Peip Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China
,
Wei Dengf Guangzhou Joincare Respiratory Medicine Co., Ltd, Guangzhou, People’s Republic of China
,
Zhong-Hui Xuq Livzon Mabpharm Inc., Zhuhai, People’s Republic of China
,
Jia-Ming Yangq Livzon Mabpharm Inc., Zhuhai, People’s Republic of China
,
Yan Zhangq Livzon Mabpharm Inc., Zhuhai, People’s Republic of China
,
Wu-Xiang Guanp Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
&
Xiong Yur Joincare Pharmaceutical Group Industry Co., Ltd., Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1910-1919 | Received 23 Mar 2022, Accepted 08 Jun 2022, Published online: 01 Aug 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.